CS logo
small CS logo
St. Vincenz Krankenhaus

Limburg, Germany
General hospital in Limburg an der Lahn, Hessen
Auf dem Schafsberg, 65549 Limburg an der Lahn

About St. Vincenz Krankenhaus


"Lebensrettung, glückliche Geburt und kompetente Behandlung von ganz klein bis ganz groß: Das St. Vincenz Limburg ist Krankenhaus der Schwerpunktversorgung und Akademisches Lehrkrankenhaus der Justus-Liebig-Universität Gießen. Hier ist ein Onkologischer Schwerpunkt mit zertifiziertem Brustzentrum und Stroke Unit angesiedelt; ein Institut für Pathologie ist angegliedert. Darüber hinaus betreibt die Trägergesellschaft eine Akademie für Gesundheitsfachberufe, die sog. BILDUNGSWERKstadt. Mit ihren 1800 Mitarbeiter:innen, 150 Ausbildungsplätzen und rund 70 hochspezialisierten Berufsbildern nimmt die Klinik eine bedeutende Position als Wirtschaftsfaktor der Region ein."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
2
German CLL Study Group
2
AGO Research GmbH
1
Karolinska University Hospital
1
Medical Research Council
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Spanish Breast Cancer Research Group
1
Total Rows: 8

Clinical Trials at St. Vincenz Krankenhaus


During the past decade, St. Vincenz Krankenhaus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years112211000000Started TrialsCompleted Trails2020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
2005-11-01
2018-08-01
Completed
592
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
2006-04-01
Completed
1,520
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
2007-11-06
2014-07-24
Completed
380
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
2007-02-01
2022-01-01
Unknown status
2,017
Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
2010-09-01
2012-10-01
Completed
1,012

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "St. Vincenz Krankenhaus" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials sponsored, "German CLL Study Group" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Karolinska University Hospital" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincenz Krankenhaus" #1 collaborator was "German Breast Group" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4Daiichi Sankyo Europe,GmbH, a Daiichi SankyoCompany: 2Daiichi Sankyo Europe,GmbH, a Daiichi SankyoCompany: 2German CLL Study Group: 2German CLL Study Group: 2AGO Research GmbH: 1AGO Research GmbH: 1Karolinska University Hospital: 1Karolinska University Hospital: 1Medical Research Council: 1Medical Research Council: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 1Spanish Breast CancerResearch Group: 1Spanish Breast CancerResearch Group: 1

Created with Highcharts 11.1.0Top CollaboratorsGerman Breast Group: 2German Breast Group: 2ARCAGY/ GINECO GROUP: 1ARCAGY/ GINECO GROUP: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1AstraZeneca: 1AstraZeneca: 1Australia New ZealandGynaecologicalOncology Group: 1Australia New ZealandGynaecologicalOncology Group: 1Austrian Breast &Colorectal Cancer StudyGroup: 1Austrian Breast &Colorectal Cancer StudyGroup: 1Cancer Trials Ireland: 1Cancer Trials Ireland: 1Grupo Español deLeucemia LinfocíticaCrónica (GELLC): 1Grupo Español deLeucemia LinfocíticaCrónica (GELLC): 1Gruppo Italiano MalattieEMatologiche dell'Adulto(GIMEMA): 1Gruppo Italiano MalattieEMatologiche dell'Adulto(GIMEMA): 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Clinical Trials Conditions at St. Vincenz Krankenhaus


According to Clinical.Site data, the most researched conditions in "St. Vincenz Krankenhaus" are "Lymphoma" (4 trials), "Breast Cancer" (2 trials), "Hypercholesterolemia" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Cardiovascular Diseases" (1 trials). Many other conditions were trialed in "St. Vincenz Krankenhaus" in a lesser frequency.

Clinical Trials Intervention Types at St. Vincenz Krankenhaus


Most popular intervention types in "St. Vincenz Krankenhaus" are "Drug" (11 trials), "Biological" (7 trials), "Other" (3 trials), "Radiation" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "vincristine sulfate" (4 trials) and "radiation therapy" (3 trials). Other intervention names were less common.

Clinical Trials Genders at St. Vincenz Krankenhaus


The vast majority of trials in "St. Vincenz Krankenhaus" are 9 trials for "All" genders and 4 trials for "Female" genders.

Clinical Trials Status at St. Vincenz Krankenhaus


Currently, there are NaN active trials in "St. Vincenz Krankenhaus". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in St. Vincenz Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Vincenz Krankenhaus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 9Phase 3: 9Phase 2: 1Phase 2: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Recruiting: 2Recruiting: 2Active, not recruiting: 1Active, not recruiting: 1Unknown status: 1Unknown status: 1